(Q33495553)
Statements
1 reference
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration (English)
1 reference
Gerrits CJ
1 reference
Creemers GJ
1 reference
Schellens JH
1 reference
Wissel P
1 reference
Planting AS
1 reference
Kunka R
1 reference
Selinger K
1 reference
de Boer-Dennert M
1 reference
Marijnen Y
1 reference
Harteveld M
1 reference
Verweij J
1 reference
1 March 1996
1 reference
1 reference
744-750
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference